Professional Documents
Culture Documents
DynamaticTech BUY Emkay 01.06.17
DynamaticTech BUY Emkay 01.06.17
Rating Upside
BUY () 30.3 %
Change in Estimates
Dynamatic Technologies (DYTC) operational performance was below our expectations.
Revenues declined by 2.5% YoY. EBIDTAM declined by 330bps YoY and APAT declined EPS Chg FY18E/FY19E (%) (13.7)/NA
by 86% YoY. Target Price change (%) (4.1)
While revenues in the hydraulics and aerospace segments increased by 3% and 15% YoY, Target Period (Months) 12
it declined by 10% YoY in the automotive segment mainly impacted by lower utilisations Previous Reco ACCUMULATE
and demonetisation linked declining sales. Emkay vs Consensus
DYTC has received incremental orders in its automotive segment and deliveries have EPS Estimates
commenced from Q1FY18. With increasing utilization levels, management expects the FY18E FY19E
India automotive segment to break even in FY18. Emkay 95.7 148.7
While we retain FY19E EPS, we have downgraded FY18E EPS by 13.7% to factor the Consensus 104.6 147.7
likely retrenchment cost associated with the rationalization of workforce in the Chennai Mean Consensus TP (12M) Rs 3,334
units. We recommend BUY with SoTP based target price of Rs3,396. Stock Details
Bloomberg Code DYTC IN
Declining auto sales weighing down performance: DYTC reported revenues of
Face Value (Rs) 10
Rs3.8bn (-3% YoY) below our estimates of Rs5bn. Revenues in the aerospace segment
Shares outstanding (mn) 6
increased by 15% YoY to Rs902mn as deliveries for the new projects gain traction – India
revenues increased by 25% YoY to Rs653mn while UK revenues declined by 5% YoY to 52 Week H/L 3,656 / 2,300
Rs250mn. EBITM in the aerospace segment declined by 990bps to 23.3% as higher M Cap (Rs bn/USD bn) 17 / 0.26
proportion of Airbus phase II orders (raw materials billed in DYTC) were executed during Daily Avg Volume (nos.) 2,278
the quarter. Revenues in the hydraulic segment increased by 3% YoY to Rs700mn – India Daily Avg Turnover (US$ mn) 0.1
revenues increased by 13% YoY to Rs486mn while the UK revenues declined by 15% YoY
to Rs214mn. EBITM in the hydraulic segment improved by 40bps to 13.3%. Revenues in Shareholding Pattern Mar '17
the automotive segment declined by 10% YoY to Rs2bn impacted by demonetisation linked Promoters 50.2%
declining sales and lower deliveries to Volkswagen – standalone revenues declined by FIIs 14.7%
14% YoY to Rs188mn while the subsidiaries reported 9% YoY decline to Rs2bn. APAT at DIIs 13.2%
consolidated level was impacted by one-time expense of Rs101mn related to the
Public and Others 22.0%
foreclosure of high cost borrowings.
Price Performance
Recommend BUY: Order book in the aerospace segment stands at over Rs60bn to be
executed over next ten years. Revenues in the aerospace segments is likely to ramp up (%) 1M 3M 6M 12M
to Rs6bn in FY20 (existing Rs3.5bn) as execution gains traction at the new aerospace Absolute (3) (10) (13) 4
facility in Bengaluru. In the automotive segment, DYTC has received incremental orders Rel. to Nifty (7) (17) (25) (11)
from Honda, Turbo Energy, Haldex, Ford, Daimler Benz etc., The Company is in the Relative price chart
process of rationalizing the workforce in its Chennai foundry and machining units and is 3375 Rs % 30
2595 -10
Emkay Research is also available on www.emkayglobal.com, Bloomberg EMKAY<GO>, Reuters and DOWJONES.
Dynamatic Technologies (DYTC IN) India Equity Research | Result Update
Emkay Research is also available on www.emkayglobal.com, Bloomberg EMKAY<GO>, Reuters and DOWJONES.
Emkay Research is also available on www.emkayglobal.com, Bloomberg EMKAY<GO>, Reuters and DOWJONES.
Emkay Research is also available on www.emkayglobal.com, Bloomberg EMKAY<GO>, Reuters and DOWJONES.
Emkay Research is also available on www.emkayglobal.com, Bloomberg EMKAY<GO>, Reuters and DOWJONES.
Emkay Research is also available on www.emkayglobal.com, Bloomberg EMKAY<GO>, Reuters and DOWJONES.
Emkay Research is also available on www.emkayglobal.com, Bloomberg EMKAY<GO>, Reuters and DOWJONES.
Segment EBIT
Hydraulics 334 260 234 269 364 426
Automotive 211 234 90 (91) 169 274
Aerospace 571 540 656 886 967 1,264
Others - (49) (93) - - -
Total 1,117 985 887 1,064 1,500 1,964
Corporate expenditure 0 (20) (0) (46) 1 (0)
Operating Income 1,117 1,005 887 1,110 1,499 1,965
Other Income 35 103 50 59 20 23
Interest expenses 997 800 728 741 666 666
PBT before exceptionals 155 308 209 428 853 1,321
Exceptional Income/(Expenses) 103 191 - - - -
Extraordinary income/(expenses) - - - - - -
PBT after exceptionals and before
258 499 209 428 853 1,321
MI and share of profit/(loss) in Assoc/ JV
Emkay Research is also available on www.emkayglobal.com, Bloomberg EMKAY<GO>, Reuters and DOWJONES.
Emkay Research is also available on www.emkayglobal.com, Bloomberg EMKAY<GO>, Reuters and DOWJONES.
Balance Sheet
Y/E Mar (Rs mn) FY15 FY16 FY17 FY18E FY19E
Equity share capital 63 63 63 63 63
Reserves & surplus 2,453 2,513 2,401 2,992 3,912
Net worth 2,517 2,576 2,464 3,055 3,975
Minority Interest 0 0 0 0 0
Loan Funds 5,167 5,958 6,245 6,245 6,245
Net deferred tax liability 276 253 232 232 232
Total Liabilities 7,959 8,787 8,941 9,532 10,452
Net block 6,435 6,266 6,479 6,243 5,988
Investment 0 1 7 7 7
Current Assets 5,019 5,261 5,766 6,827 8,326
Cash & bank balance 761 627 826 1,641 2,447
Other Current Assets 300 240 182 182 182
Current liabilities & Provision 3,539 3,027 3,555 3,788 4,112
Net current assets 1,480 2,234 2,211 3,039 4,214
Misc. exp 0 0 0 0 0
Total Assets 7,959 8,787 8,941 9,532 10,452
Cash Flow
Y/E Mar (Rs mn) FY15 FY16 FY17 FY18E FY19E
PBT (Ex-Other income) (NI+Dep) 206 159 368 833 1,298
Other Non-Cash items (419) 71 (21) 0 0
Chg in working cap (308) (911) 201 (13) (369)
Operating Cashflow 1,160 424 1,674 1,827 1,822
Capital expenditure (106) (598) (714) (350) (350)
Free Cash Flow 1,054 (174) 960 1,477 1,472
Investments 0 (1) (6) 0 0
Other Investing Cash Flow 487 70 (110) 0 0
Investing Cashflow 483 (479) (770) (330) (327)
Equity Capital Raised 498 (43) 0 0 0
Loans Taken / (Repaid) (775) 791 287 0 0
Dividend paid (incl tax) 0 0 (258) (15) (23)
Other Financing Cash Flow (296) (119) 0 0 0
Financing Cashflow (1,373) (99) (712) (682) (689)
Net chg in cash 271 (154) 191 815 806
Opening cash position 441 761 627 826 1,641
Closing cash position 761 627 826 1,641 2,447
Source: Company, Emkay Research
Emkay Research is also available on www.emkayglobal.com, Bloomberg EMKAY<GO>, Reuters and DOWJONES.
Key Ratios
Profitability (%) FY15 FY16 FY17 FY18E FY19E
EBITDA Margin 9.3 9.4 11.0 12.2 13.4
EBIT Margin 6.2 5.9 7.4 8.8 10.2
Effective Tax Rate 69.0 41.2 42.2 28.9 28.6
Net Margin 0.6 0.8 1.6 3.6 4.9
ROCE 14.1 11.2 13.3 16.5 20.0
ROE 4.8 4.9 10.0 22.4 27.2
RoIC 14.0 11.9 14.2 19.5 25.7
Emkay Research is also available on www.emkayglobal.com, Bloomberg EMKAY<GO>, Reuters and DOWJONES.
2000
1000
01-Aug-14
01-Dec-14
01-Apr-15
01-Aug-15
01-Dec-15
01-Apr-16
01-Aug-16
01-Dec-16
01-Apr-17
01-Feb-15
01-Feb-16
01-Feb-17
01-Jun-14
01-Jun-15
01-Jun-16
01-Oct-14
01-Oct-15
01-Oct-16
Source: Bloomberg, Company, Emkay Research
Emkay Research is also available on www.emkayglobal.com, Bloomberg EMKAY<GO>, Reuters and DOWJONES.
DISCLAIMERS AND DISCLOSURES: Emkay Global Financial Services Limited (CIN-L67120MH1995PLC084899) and its affiliates are a full-service, brokerage, investment banking, investment
management and financing group. Emkay Global Financial Services Limited (EGFSL) along with its affiliates are participants in virtually all securities trading markets in India. EGFSL was established in 1995
and is one of India's leading brokerage and distribution house.EGFSL is a corporate trading member of Bombay Stock Exchange Limited (BSE), National Stock Exchange of India Limited(NSE), MCX Stock
Exchange Limited (MCX-SX).EGFSL along with its subsidiaries offers the most comprehensive avenues for investments and is engaged in the businesses including stock broking (Institutional and retail),
merchant banking, commodity broking, depository participant, portfolio management, insurance broking and services rendered in connection with distribution of primary market issues and financial products
like mutual funds, fixed deposits. Details of associates are available on our website i.e. www.emkayglobal.com
EGFSL is registered as Research Analyst with SEBI bearing registration Number INH000000354 as per SEBI (Research Analysts) Regulations, 2014. EGFSL hereby declares that it has not defaulted with
any stock exchange nor its activities were suspended by any stock exchange with whom it is registered in last five years, except that NSE had disabled EGFSL from trading on October 05, October 08 and
October 09, 2012 for a manifest error resulting into a bonafide erroneous trade on October 05, 2012. However, SEBI and Stock Exchanges have conducted the routine inspection and based on their
observations have issued advice letters or levied minor penalty on EGFSL for certain operational deviations in ordinary/routine course of business. EGFSL has not been debarred from doing business by
any Stock Exchange / SEBI or any other authorities; nor has its certificate of registration been cancelled by SEBI at any point of time.
EGFSL offers research services to clients as well as prospects. The analyst for this report certifies that all of the views expressed in this report accurately reflect his or her personal views about the subject
company or companies and its or their securities, and no part of his or her compensation was, is or will be, directly or indirectly related to specific recommendations or views expressed in this report.
Other disclosures by Emkay Global Financial Services Limited (Research Entity) and its Research Analyst under SEBI (Research Analyst) Regulations, 2014 with reference to the subject
company(s) covered in this report-:
EGFSL or its associates may have financial interest in the subject company.
Research Analyst or his/her relative’s financial interest in the subject company. (NO)
EGFSL or its associates and Research Analyst or his/her relative’s does not have any material conflict of interest in the subject company. The research Analyst or research entity (EGFSL) have not been
engaged in market making activity for the subject company.
EGFSL or its associates may have actual/beneficial ownership of 1% or more securities of the subject company at the end of the month immediately preceding the date of publication of Research Report.
Research Analyst or his/her relatives have actual/beneficial ownership of 1% or more securities of the subject company at the end of the month immediately preceding the date of publication of Research
Report: (NO)
EGFSL or its associates may have received any compensation including for investment banking or merchant banking or brokerage services from the subject company in the past 12 months. EGFSL or its
associates may have received compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past 12 months. EGFSL or
its associates may have received any compensation or other benefits from the Subject Company or third party in connection with the research report. Subject Company may have been client of EGFSL or
its associates during twelve months preceding the date of distribution of the research report and EGFSL may have co-managed public offering of securities for the subject company in the past twelve months.
The research Analyst has served as officer, director or employee of the subject company: (NO)
The Research Analyst has received any compensation from the subject company in the past twelve months: (NO)
The Research Analyst has managed or co‐managed public offering of securities for the subject company in the past twelve months: (NO)
The Research Analyst has received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months: (NO)
The Research Analyst has received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months:
(NO)
The Research Analyst has received any compensation or other benefits from the subject company or third party in connection with the research report: (NO)
EGFSL and/or its affiliates may seek investment banking or other business from the company or companies that are the subject of this material. Our salespeople, traders, and other professionals may provide
oral or written market commentary or trading strategies to our clients that reflect opinions that are contrary to the opinions expressed herein, and our proprietary trading and investing businesses may make
investment decisions that may be inconsistent with the recommendations expressed herein. In reviewing these materials, you should be aware that any or all of the foregoing, among other things, may give
rise to real or potential conflicts of interest including but not limited to those stated herein. Additionally, other important information regarding our relationships with the company or companies that are the
subject of this material is provided herein. This report is not directed to, or intended for distribution to or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or
other jurisdiction where such distribution, publication, availability or use would be contrary to law or regulation or which would subject EGFSL or its group companies to any registration or licensing requirement
within such jurisdiction. Specifically, this document does not constitute an offer to or solicitation to any U.S. person for the purchase or sale of any financial instrument or as an official confirmation of any
transaction to any U.S. person. Unless otherwise stated, this message should not be construed as official confirmation of any transaction. No part of this document may be distributed in Canada or used by
private customers in United Kingdom. All material presented in this report, unless specifically indicated otherwise, is under copyright to Emkay. None of the material, nor its content, nor any copy of it, may
be altered in any way, transmitted to, copied or distributed to any other party, without the prior express written permission of EGFSL . All trademarks, service marks and logos used in this report are trademarks
or registered trademarks of EGFSL or its Group Companies. The information contained herein is not intended for publication or distribution or circulation in any manner whatsoever and any unauthorized
reading, dissemination, distribution or copying of this communication is prohibited unless otherwise expressly authorized. Pl ease ensure that you have read “Risk Disclosure Document for Capital Market
and Derivatives Segments” as prescribed by Securities and Exchange Board of India before investing in Indian Securities Market. In so far as this report includes current or historic information, it is believed
to be reliable, although its accuracy and completeness cannot be guaranteed.
Emkay Research is also available on www.emkayglobal.com, Bloomberg EMKAY<GO>, Reuters and DOWJONES. www.emkayglobal.com
May 31, 2017 13